QUANTUM X LABS INC. quarterly report, Q1 FY2014

Business context and reporting period

This Form 10-Q covers the three months ended March 31, 2014. The filing identifies the registrant as Zaxis International Inc., not Quantum X Labs Inc. Zaxis reports that it has no current operations, is a shell company, and is pursuing a business combination; it has not identified a target.

Financial results and liquidity

MetricQ1 2014Q1 2013 / prior balance
Revenue$0$0
General and administrative expense$7,750$11,950
Interest expense$2,371$2,550
Net loss$10,121$14,500
Operating cash used$2,500$3,700
Cash at period end$0$0
Total liabilities$288,900$278,779 at Dec. 31, 2013
Stockholders’ deficit$288,900$278,779 at Dec. 31, 2013

With no revenue, a profit margin is not meaningful. The company had no assets and no available cash at March 31. Current liabilities were $163,900 and long-term convertible notes were $125,000. The balance sheet lists $124,229 due to an unrelated party; the MD&A instead states $124,220, an inconsistency to verify.

Material changes and unusual items

Net loss narrowed by $4,379 year over year, mainly as general and administrative expense fell $4,200 (35%), which management attributed primarily to lower officer compensation and office costs. Interest expense decreased slightly following reductions in note interest rates.

During the quarter, $85,000 of convertible notes and related accrued interest, and $40,000 of advances, were transferred from the president and principal shareholder to unaffiliated parties. The company reported $125,000 in outstanding convertible notes at quarter-end. In March, the notes’ interest rates were reduced to 1% and maturities extended to July 1, 2015; conversion prices were adjusted, including to $0.01 for the two older notes. A separate $40,000 note for services has a $0.005 conversion price. These terms could result in substantial share issuance and dilution.

Operating cash use was funded by $2,500 in financing advances. The cash flow statement reports no change in cash. The company had 1,695,126 common shares outstanding at May 15, 2014; management states it owns 82%.

Outlook, risks, and controls

Management intends to use limited resources to seek a business combination, but identifies no target, financing agreement, or committed funding. It cautions that financing may not be available on acceptable terms and that a combination may require issuing restricted shares, causing dilution or a change in control. A combination may involve an early-stage or financially unstable business, and the company may be dependent on a single business after a transaction.

The filing states that losses, negative operating cash flows, and no revenue raise substantial doubt about the company’s ability to continue as a going concern. Management says the statements include no adjustments for this uncertainty. Disclosure controls and procedures were concluded to be ineffective as of March 31, 2014, due to lack of segregation of duties. No material changes to internal control over financial reporting were reported during the quarter. The filing reports no legal proceedings, unregistered equity sales, or defaults upon senior securities.

Important facts for investors to verify

  • Confirm the registrant’s identity: the supplied filing is for Zaxis International Inc., while the request names Quantum X Labs Inc.
  • Reconcile the $124,229 balance-sheet amount with the $124,220 stated in MD&A.
  • Review the convertible-note holders, transfer terms, conversion prices, accrued interest, and potential dilution.
  • Assess the company’s ability to fund operations and complete a business combination given zero cash, no revenue, and the stated going-concern uncertainty.
  • Consider the ineffective disclosure controls and the filing’s stated lack of segregation of duties.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.